Envoy Medical Inc.
Envoy Medical Inc. (COCH): 7 pipeline candidates · ~13 mo cash runway · 1 clinical trial. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
12.9 months
D/E 1.90
Lead: Approved
7 candidates
N/A
6 buys · 0 sells (180d)
A transparent, data-derived signal for Envoy Medical Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$50.5M
Cash
$25.3M
Quarterly Burn
$6.1M
Runway
12.9 mo
Revenue
$39K
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (7 candidates)
| Drug | Phase |
|---|---|
| acclaim ci | Preclinical |
| envoycem | — |
| envoycem | — |
| esteem | Approved |
| esteem fi-amei | Approved |
| marketing of its acclaim ci device | Approved |
| marketing of its acclaim ci device | Approved |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
29
Total value held
$2.6M
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 1,763,344 | $1.2M |
| dsg capital advisors, llc | 625,000 | $416K |
| geode capital management, llc | 521,824 | $347K |
| vanguard fiduciary trust co | 294,721 | $196K |
| arcus capital partners, llc | 187,573 | $125K |
| northern trust corp | 111,050 | $74K |
| morgan stanley | 73,900 | $49K |
| ubs group ag | 70,459 | $47K |
| blackrock, inc. | 47,514 | $32K |
| goldman sachs group inc | 36,462 | $24K |
Showing top 10 of 29 institutional holders of Envoy Medical Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Envoy Medical Inc.'s pipeline?
Envoy Medical Inc. (COCH) has 7 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Envoy Medical Inc.'s lead drug candidate?
Envoy Medical Inc.'s most advanced tracked candidate is acclaim ci (Preclinical) for Severe-to-profound sensorineural hearing loss.
What is Envoy Medical Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Envoy Medical Inc. has approximately 12.9 months of cash runway.
What is Envoy Medical Inc.'s market capitalization?
Envoy Medical Inc.'s market capitalization is approximately $50.5M.
Who is the CEO of Envoy Medical Inc.?
Mr. Brent T. Lucas Esq. is the chief executive officer of Envoy Medical Inc. (COCH).
Get the full picture on Envoy Medical Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.